Non–small cell lung cancer, PD-L1, and the pathologist

KM Kerr, MC Nicolson - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Context Although most primary cancers of the lung carry a heavy mutational load and will
potentially present many “nonself” antigens to the immune system, there are a wide range of …

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

KM Kerr, MC Nicolson - Archives of pathology & …, 2016 - pubmed.ncbi.nlm.nih.gov
Context Although most primary cancers of the lung carry a heavy mutational load and will
potentially present many" nonself" antigens to the immune system, there are a wide range of …

Non–Small Cell Lung Cancer, PD-L1, and the Pathologist

KM Kerr, MC Nicolson - Archives of Pathology & Laboratory Medicine, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Context</jats: title>< jats: p> Although most primary cancers of
the lung carry a heavy mutational load and will potentially present many “nonself” antigens …

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

KM Kerr, MC Nicolson - Archives of Pathology & Laboratory Medicine, 2016 - go.gale.com
Context.--Although most primary cancers of the lung carry a heavy mutational load and will
potentially present many" nonself" antigens to the immune system, there are a wide range of …

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist.

KM Kerr, MC Nicolson - Archives of Pathology & Laboratory …, 2016 - search.ebscohost.com
Context.--Although most primary cancers of the lung carry a heavy mutational load and will
potentially present many" nonself" antigens to the immune system, there are a wide range of …

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist

MC Nicolson - Archives of Pathology & Laboratory Medicine, 2016 - search.proquest.com
Objective.-To discuss the possibility of biomarker selection of patients for these therapies.
This is becoming a much debated issue, and the immunohistochemical detection of …

Non-Small Cell Lung Cancer, PD-L1, and the Pathologist.

KM Kerr, MC Nicolson - Archives of Pathology & Laboratory …, 2016 - europepmc.org
Objective To discuss the possibility of biomarker selection of patients for these therapies.
This is becoming a much debated issue, and the immunohistochemical detection of …